欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7569/001
药品名称LevaTROP 2.5 mg/ml concentrate for solution for infusion
活性成分
    • levosimendan 2.5 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Pharmaselect International Beteiligungs GmbH Ernst-Melchior-Gasse 20 Leopoldstadt 1020 Vienna Austria
参考成员国 - 产品名称Germany (DE)
LevaTROP 2,5 mg/ ml Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Austria (AT)
    • Poland (PL)
      SENSITAN
    • Hungary (HU)
      LevaTROP 2,5 mg/ml koncentrátum oldatos infúzióhoz
    • Czechia (CZ)
      LevaTROP 2,5 mg/ml koncentrát pro infuzní roztok
    • Romania (RO)
      LevaTROP 2,5 mg/ml concentrat pentru soluţie perfuzabilă
    • Slovakia (SK)
    • Croatia (HR)
许可日期2024/06/25
最近更新日期2024/06/25
药物ATC编码
    • C01CX08 levosimendan
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase